Pranita D. Tamma, MD, MHS

Pranita D. Tamma, MD, MHS

Johns Hopkins University

H-index: 54

North America-United States

About Pranita D. Tamma, MD, MHS

Pranita D. Tamma, MD, MHS, With an exceptional h-index of 54 and a recent h-index of 48 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of gram-negative resistance, antibiotic stewardship.

His recent articles reflect a diverse array of research interests and contributions to the field:

Transition to Oral Antibiotic Therapy for Hospitalized Adults With Gram-Negative Bloodstream Infections

Lessons Learned from a National Hospital Antibiotic Stewardship Implementation Project

Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making

Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage

The metallo-β-lactamases strike back: emergence of taniborbactam escape variants

Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections

A multi-center validation of the electronic health record admission source and discharge location fields against the clinical notes for identifying inpatients with long-term …

Identifying effective durations of antibiotic therapy for the treatment of carbapenem-resistant enterobacterales bloodstream infections: a multicenter observational study

Pranita D. Tamma, MD, MHS Information

University

Position

School of Medicine

Citations(all)

11396

Citations(since 2020)

8702

Cited By

5395

hIndex(all)

54

hIndex(since 2020)

48

i10Index(all)

153

i10Index(since 2020)

133

Email

University Profile Page

Johns Hopkins University

Google Scholar

View Google Scholar Profile

Pranita D. Tamma, MD, MHS Skills & Research Interests

gram-negative resistance

antibiotic stewardship

Top articles of Pranita D. Tamma, MD, MHS

Title

Journal

Author(s)

Publication Date

Transition to Oral Antibiotic Therapy for Hospitalized Adults With Gram-Negative Bloodstream Infections

JAMA Network Open

Drew W Engers

Pranita D Tamma

Suiyini Fiawoo

Karen Fong

Ripal Jariwala

...

2024/1/2

Lessons Learned from a National Hospital Antibiotic Stewardship Implementation Project

The Joint Commission Journal on Quality and Patient Safety

Sara E Cosgrove

Roy Ahn

Prashila Dullabh

Janna Gordon

Melissa A Miller

...

2024/4/6

Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making

Antimicrobial Stewardship & Healthcare Epidemiology

Jerald P Cherian

Taylor N Helsel

George F Jones

Zunaira Virk

Alejandra Salinas

...

2024/1

Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage

Journal of Antimicrobial Chemotherapy

Aliaa Fouad

Samantha E Nicolau

Pranita D Tamma

Patricia J Simner

David P Nicolau

...

2024/4/2

The metallo-β-lactamases strike back: emergence of taniborbactam escape variants

Pranita D Tamma

Jose M Munita

2024/2/7

Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections

European Journal of Clinical Microbiology & Infectious Diseases

Julia Herrmann

Anne-Valérie Burgener-Gasser

Daniel Goldenberger

Jan Roth

Maja Weisser

...

2024/2

A multi-center validation of the electronic health record admission source and discharge location fields against the clinical notes for identifying inpatients with long-term …

Infection Control & Hospital Epidemiology

Katherine E Goodman

Monica Taneja

Laurence S Magder

Eili Y Klein

Mark Sutherland

...

2024/4/18

Identifying effective durations of antibiotic therapy for the treatment of carbapenem-resistant enterobacterales bloodstream infections: a multicenter observational study

Clinical Infectious Diseases

Caitlin L Soto

Alice J Hsu

Jae Hyoung Lee

Kathryn Dzintars

Rebecca Choudhury

...

2024/1/15

Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis with Sulbactam-Durlobactam

Clinical Infectious Diseases

Pranita D Tamma

Shanan Immel

Sara M Karaba

Caitlin L Soto

Rick Conzemius

...

2024/4/17

215. Shorter vs. Longer Duration of Treatment in Patients with Ceftriaxone-resistant and Ceftriaxone-susceptible Escherichia coli Bloodstream Infections

Open Forum Infectious Diseases

Natalie A Mackow

Lizhao Ge

Lauren Komarow

Wanying Shao

Erica Herc

...

2023/12

An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another …

Open Forum Infectious Diseases

Patricia J Simner

Yehudit Bergman

Rick Conzemius

Emily Jacobs

Tsigereda Tekle

...

2023/7

Trends in pediatric community-onset Staphylococcus aureus antibiotic susceptibilities over a five-year period in a multihospital health system

Antimicrobial Stewardship & Healthcare Epidemiology

Erica C Prochaska

Shaoming Xiao

Pranita D Tamma

Anna Sick-Samuels

Christina Schumacher

...

2023/1

The clinical utility of MRSA nasal surveillance swabs in ruling-out MRSA infections in children

Journal of the Pediatric Infectious Diseases Society

Emily R Diseroad

Pranita D Tamma

Rebecca G Same

Alice J Hsu

2023/3/1

Defining the optimal duration of therapy for hospitalized patients with complicated urinary tract infections and associated bacteremia

Clinical Infectious Diseases

John McAteer

Jae Hyoung Lee

Sara E Cosgrove

Kathryn Dzintars

Suiyini Fiawoo

...

2023/5/1

Trimethoprim–Sulfamethoxazole for Pediatric Osteoarticular Infections

Journal of the Pediatric Infectious Diseases Society

Lauren M McDaniel

Suiyini Fiawoo

Pranita D Tamma

Rebecca G Same

2023/10/1

Boosting of Voriconazole Levels With Omeprazole, A CYP450 2C19 Inhibitor

The Pediatric Infectious Disease Journal

Alice J Hsu

Carlton KK Lee

John McAteer

Sean X Zhang

Pranita D Tamma

2023/6/1

1109. A multicenter, observational study to compare the effectiveness of C eftazidime-A vibactam versus C eftolozane-T azobactam for multidrug-resistant Pseudomonas aeruginosa …

Open Forum Infectious Diseases

Ryan K Shields

Lilian M Abbo

Renee Ackley

Samuel L Aitken

Benjamin Albrecht

...

2023/12

Antimicrobial Agents and Chemotherapy Launches a New Section Focused on Innovative Antimicrobial Stewardship Studies

Antimicrobial agents and chemotherapy

Pranita D Tamma

Cesar A Arias

Ryan K Shields

2023/6/15

Clinical outcomes and risk factors for carbapenem-resistant Enterobacterales bloodstream infection in solid organ transplant recipients

Transplantation

Judith A Anesi

Ebbing Lautenbach

Kerri A Thom

Pranita D Tamma

Emily A Blumberg

...

2023/1/1

2487. Which Extended-Spectrum β-Lactamase-Producing Enterobacterales Colonize the Gastrointestinal Tract of High-Risk Patients?

Open Forum Infectious Diseases

Haley Stambaugh

Shawna Lewis

Emily B Jacobs

Dariusz A Hareza

Yehudit Bergman

...

2023/12

See List of Professors in Pranita D. Tamma, MD, MHS University(Johns Hopkins University)